Literature DB >> 11679923

Frequency of anovulation and early menopause among women enrolled in selected adult AIDS clinical trials group studies.

R A Clark1, K Mulligan, E Stamenovic, B Chang, H Watts, J Andersen, K Squires, C Benson.   

Abstract

To obtain information on the prevalence of anovulation and early menopause and on pituitary-gonadal function among human immunodeficiency virus type 1-infected women, a study was undertaken that used stored serum samples from women aged 20-42 years who participated in selected Adult AIDS Clinical Trials Group protocols. Defined progesterone and follicle-stimulating hormone (FSH) levels were considered presumptive evidence of ovulation and of menopause, respectively. Anovulation occurred in 16 (48%) of 33 women for whom progesterone levels were tested; early menopause occurred in 2 (8%) of 24 women for whom FSH levels were tested. No statistically significant differences were seen in the demographic and clinical characteristics of anovulatory and ovulatory women, although women who ovulated had higher CD4 T cell counts and were less likely to have reported a recent change in menstrual periods. These data support the findings of prior studies of increased frequency of amenorrhea and/or irregular menstrual cycles, particularly among women with lower CD4 T cell counts.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11679923     DOI: 10.1086/323999

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

Review 1.  Care of the human immunodeficiency virus-infected menopausal woman.

Authors:  Helen Elizabeth Cejtin
Journal:  Am J Obstet Gynecol       Date:  2011-12-30       Impact factor: 8.661

Review 2.  Human immunodeficiency virus/acquired immunodeficiency syndrome and infertility: emerging problems in the era of highly active antiretrovirals.

Authors:  Vitaly A Kushnir; William Lewis
Journal:  Fertil Steril       Date:  2011-06-30       Impact factor: 7.329

3.  Reduced ovarian reserve relates to monocyte activation and subclinical coronary atherosclerotic plaque in women with HIV.

Authors:  Sara E Looby; Kathleen V Fitch; Suman Srinivasa; Janet Lo; Danielle Rafferty; Amanda Martin; Judith C Currier; Steven Grinspoon; Markella V Zanni
Journal:  AIDS       Date:  2016-01-28       Impact factor: 4.177

4.  Initiation of puberty in mice following decellularized ovary transplant.

Authors:  Monica M Laronda; Adam E Jakus; Kelly A Whelan; Jason A Wertheim; Ramille N Shah; Teresa K Woodruff
Journal:  Biomaterials       Date:  2015-02-14       Impact factor: 12.479

5.  Low bone-mineral density in patients with HIV: pathogenesis and clinical significance.

Authors:  Michael T Yin; Elizabeth Shane
Journal:  Curr Opin Endocrinol Diabetes       Date:  2006-12-01

Review 6.  Gynecologic issues in the HIV-infected woman.

Authors:  Helen E Cejtin
Journal:  Infect Dis Clin North Am       Date:  2008-12       Impact factor: 5.982

Review 7.  Hypogonadism in human immunodeficiency virus-positive men.

Authors:  Jane Ashby; David Goldmeier; Hossein Sadeghi-Nejad
Journal:  Korean J Urol       Date:  2014-01-15

Review 8.  Women and HIV infection: the makings of a midlife crisis.

Authors:  Nanette Santoro; Maria Fan; BatSheva Maslow; Ellie Schoenbaum
Journal:  Maturitas       Date:  2009-09-23       Impact factor: 4.342

9.  Fragility fractures and bone mineral density in HIV positive women: a case-control population-based study.

Authors:  J Prior; D Burdge; E Maan; R Milner; C Hankins; M Klein; S Walmsley
Journal:  Osteoporos Int       Date:  2007-07-31       Impact factor: 4.507

10.  Combined HIV-1 Tat and oxycodone activate the hypothalamic-pituitary-adrenal and -gonadal axes and promote psychomotor, affective, and cognitive dysfunction in female mice.

Authors:  Mohammed F Salahuddin; Alaa N Qrareya; Fakhri Mahdi; Dejun Jackson; Matthew Foster; Tamara Vujanovic; J Gaston Box; Jason J Paris
Journal:  Horm Behav       Date:  2019-12-13       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.